← Open Payments lookup

LINDSAY BITTO: Open Payments

NPI 1972904845 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,985 in 91 payments from 26 companies in 2025. Trend: 2023 $2,049 · 2024 $2,038 · 2025 $2,985

Food & beverage: $2,975Education: $9
CompanyPaymentsAmount
ABBVIE INC.10$430
Madrigal Pharmaceuticals8$357
GENZYME CORPORATION13$276
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$240
Janssen Biotech, Inc.9$233
Amgen Inc.2$205
Takeda Pharmaceuticals U.S.A., Inc.4$135
Dexcom, Inc.1$115
Teva Pharmaceuticals USA, Inc.1$103
Lilly USA, LLC4$94

Products named: DUPIXENT, REZDIFFRA, RINVOQ, XIFAXAN, TREMFYA, DEXCOM G7 GSS (161), ENTYVIO, REPATHA.

Industry payments across MD — which companies pay providers there.